Registered Trials

• NCT05442684

  Phase 3

  Total Enrollment: 1,350

  Official Trial Registration:

  • NCT05442684(Opens in new tab/window)

• NCT05169008

  Phase 3

  Chile, Mexico

  Total Enrollment: 2,000

  Official Trial Registration:

  • NCT05169008(Opens in new tab/window)

• NCT04526990

  Phase 3

  Argentina, Chile, Mexico, Pakistan, Russian Federation

  Total Enrollment: 40,000

  Official Trial Registration:

  • NCT04526990(Opens in new tab/window)

• NCT04540419

  Phase 3

  Russian Federation

  Total Enrollment: 500

  Official Trial Registration:

  • NCT04540419(Opens in new tab/window)

• NCT05162482

  Phase 2

  Pakistan

  Total Enrollment: 1,680

  Official Trial Registration:

  • NCT05162482(Opens in new tab/window)

• ChiCTR2000031781, NCT04341389

  Phase 2

  China

  Total Enrollment: 508

  Official Trial Registration:

  • ChiCTR2000031781(Opens in new tab/window)
  • NCT04341389(Opens in new tab/window)

• NCT04566770

  Phase 2

  China

  Total Enrollment: 481

  Official Trial Registration:

  • NCT04566770(Opens in new tab/window)

• NCT05005156

  Phase 2

  Argentina

  Total Enrollment: 876

  Official Trial Registration:

  • NCT05005156(Opens in new tab/window)

• NCT05043259

  Phase 1/2

  China

  Total Enrollment: 420

  Official Trial Registration:

  • NCT05043259(Opens in new tab/window)

• NCT04840992

  Phase 1/2

  China

  Total Enrollment: 840

  Official Trial Registration:

  • NCT04840992(Opens in new tab/window)

• ChiCTR2000030906, NCT04313127

  Phase 1

  China

  Total Enrollment: 108

  Official Trial Registration:

  • ChiCTR2000030906(Opens in new tab/window)
  • NCT04313127(Opens in new tab/window)

• NCT04568811

  Phase 1

  China

  Total Enrollment: 89

  Official Trial Registration:

  • NCT04568811(Opens in new tab/window)